Mark E. Olah

4.7k total citations · 1 hit paper
59 papers, 4.0k citations indexed

About

Mark E. Olah is a scholar working on Molecular Biology, Physiology and Organic Chemistry. According to data from OpenAlex, Mark E. Olah has authored 59 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 33 papers in Physiology and 12 papers in Organic Chemistry. Recurrent topics in Mark E. Olah's work include Adenosine and Purinergic Signaling (33 papers), Pharmacological Receptor Mechanisms and Effects (18 papers) and Receptor Mechanisms and Signaling (17 papers). Mark E. Olah is often cited by papers focused on Adenosine and Purinergic Signaling (33 papers), Pharmacological Receptor Mechanisms and Effects (18 papers) and Receptor Mechanisms and Signaling (17 papers). Mark E. Olah collaborates with scholars based in United States, Hungary and United Kingdom. Mark E. Olah's co-authors include Gary L. Stiles, Kenneth A. Jacobson, Neli Melman, Robert A. Johnson, Olivier Civelli, Qun Zhou, Chuanfu Li, Carola Gallo‐Rodriguez, Xiao-duo Ji and Suhaib M. Siddiqi and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The FASEB Journal.

In The Last Decade

Mark E. Olah

56 papers receiving 4.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Molecular cloning and characterization of an adenosine receptor: the A3 adenosine receptor.

1992 567 citations Mark E. Olah, Gary L. Stiles et al. profile →

Peers

Countries citing papers authored by Mark E. Olah

Since Specialization

Citations

This map shows the geographic impact of Mark E. Olah's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark E. Olah with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark E. Olah more than expected).

Fields of papers citing papers by Mark E. Olah

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark E. Olah. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark E. Olah. The network helps show where Mark E. Olah may publish in the future.

Co-authorship network of co-authors of Mark E. Olah

This figure shows the co-authorship network connecting the top 25 collaborators of Mark E. Olah. A scholar is included among the top collaborators of Mark E. Olah based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark E. Olah. Mark E. Olah is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Trametinib and Dabrafenib: New Agents for Advanced Stage Melanoma 2014 ·(unknown), (unknown), (unknown), (unknown), Mark E. Olah	0
2	Impact of Community Pharmacists on Management of Cancer Chemotherapy and the Resulting Side Effects 2012 ·(unknown), (unknown), (unknown), (unknown), Mark E. Olah	0
3	Transcriptional regulation of episodic glucocorticoid secretion 2012 ·Molecular and Cellular Endocrinology ·Ying Liu, (unknown), (unknown), (unknown), (unknown), Mark E. Olah, Francesca Spiga, Stafford L. Lightman, Greti Aguilera	29
4	Role of salsolinol in the regulation of pituitary prolactin and peripheral dopamine release 2011 ·Reproductive Medicine and Biology ·Mark E. Olah, Ibolya Bodnár, (unknown), Béla Tóth, Miklós Vecsernyés, György M. Nagy	4
5	Dephosphorylation/inactivation of tyrosine hydroxylase at the median eminence of the hypothalamus is required for suckling-induced prolactin and adrenocorticotrop hormone responses 2010 ·Brain Research Bulletin ·Pálma Fehér, Mark E. Olah, Ibolya Bodnár, (unknown), Ildikó Bácskay, Béla Juhász, György M. Nagy, Miklós Vecsernyés	16
6	Caveolin‐1 is transported to multi‐vesicular bodies after albumin‐induced endocytosis of caveolae in HepG2 cells 2008 ·Journal of Cellular and Molecular Medicine ·Erzsébet Botos, Judith Klumperman, Viola Oorschot, Botond Z. Igyártó, Attila Magyar, Mark E. Olah, Anna L. Kiss	32
7	The role of endocannabinoids in the regulation of luteinizing hormone and prolactin release 2008 ·Molecular and Cellular Endocrinology ·Mark E. Olah, (unknown), Tibor Wenger	22
8	Interaction between salsolinol (SAL) and thyrotropin-releasing hormone (TRH) or dopamine (DA) on the secretion of prolactin in ruminants 2007 ·Domestic Animal Endocrinology ·Tsutomu HASHIZUME, (unknown), Shuichi Suzuki, Etsuko Kasuya, Hideto Kuwayama, Hiroyuki Suzuki, Mark E. Olah, (unknown)	20
9	Cyclic AMP-Dependent, Protein Kinase A-Independent Activation of Extracellular Signal-Regulated Kinase 1/2 Following Adenosine Receptor Stimulation in Human Umbilical Vein Endothelial Cells: Role of Exchange Protein Activated by cAMP 1 (Epac1) 2007 ·Journal of Pharmacology and Experimental Therapeutics ·Ying Fang, Mark E. Olah	64
10	Effect of simulated microgravity on oxidation-sensitive gene expression in PC12 cells 2006 ·Advances in Space Research ·Ohwon Kwon, Maureen A. Sartor, Craig R. Tomlinson, Ronald W. Millard, Mark E. Olah, John M. Sankovic, Rupak K. Banerjee	5
11	Structure-Activity Relationships of 9-Alkyladenine and Ribose-Modified Adenosine Derivatives at Rat A3 Adenosine Receptors 1995 ·Journal of Medicinal Chemistry ·Kenneth A. Jacobson, Suhaib M. Siddiqi, Mark E. Olah, Xiao-duo Ji, Neli Melman, (unknown), (unknown), Gary L. Stiles, Hea O. Kim	58
12	Search for New Purine- and Ribose-Modified Adenosine Analogs as Selective Agonists and Antagonists at Adenosine Receptors 1995 ·Journal of Medicinal Chemistry ·Suhaib M. Siddiqi, Kenneth A. Jacobson, John L. Esker, Mark E. Olah, Xiao-duo Ji, Neli Melman, Kamal N. Tiwari, John A. Secrist, Stewart W. Schneller	73
13	Selective Ligands for Rat A3 Adenosine Receptors: Structure-Activity Relationships of 1,3-Dialkylxanthine 7-Riboside Derivatives 1994 ·Journal of Medicinal Chemistry ·Hea Ok Kim, Xiao-duo Ji, Neli Melman, Mark E. Olah, Gary L. Stiles, Kenneth A. Jacobson	27
14	Species differences in ligand affinity at central A₃‐adenosine receptors 1994 ·Drug Development Research ·Xiao‐duo Ji, Dag Von Lubitz, Mark E. Olah, Gary L. Stiles, Kenneth A. Jacobson	71
15	Structure-Activity Relationships of 1,3-Dialkylxanthine Derivatives at Rat A3 Adenosine Receptors 1994 ·Journal of Medicinal Chemistry ·Hea Ok Kim, Xiao‐duo Ji, Neli Melman, Mark E. Olah, Gary L. Stiles, Kenneth A. Jacobson	45
16	Structure-Activity Relationships of N6-Benzyladenosine-5'-uronamides as A3-Selective Adenosine Agonists 1994 ·Journal of Medicinal Chemistry ·Carola Gallo‐Rodriguez, Xiao-duo Ji, Neli Melman, (unknown), (unknown), (unknown), Bilha Fischer, (unknown), Mark E. Olah	218
17	Molecular characterization of A₁ and A_2a adenosine receptors 1993 ·Drug Development Research ·Kenneth A. Jacobson, Philip J. M. van Galen, Xiao‐duo Ji, Vickram Ramkumar, Mark E. Olah, Gary L. Stiles	13
18	Purification and characterization of bovine cerebral cortex A1 adenosine receptor1 1990 ·Archives of Biochemistry and Biophysics ·Mark E. Olah, Kenneth A. Jacobson, Gary L. Stiles	21
19	Differential Effects of Calcium Channel Blockade and Intracellular Calcium Antagonism on Endothelium-Dependent Responses of the Rat Aorta to Drugs 1988 ·Pharmacology ·Mark E. Olah, Ralf G. Rahwan	5
20	Age-Related Changes in Responsiveness of the Rat Aorta to Depolarizing and Receptor-Mediated Contractile Stimuli and to Calcium Antagonism1 1987 ·Pharmacology ·Mark E. Olah, Ralf G. Rahwan	11

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact